In this study, the results of western blotting and qRT-PCR demonstrated that treatment with 18β-GRA in GC cells led to significant suppression of KRAS and p-ERK1/2 expression in the MAPK signaling pathway. The gene discussed is MAPK3; the disease is gastric cancer.